多巴胺替代疗法的对皮质结构的影响在帕金森病的皮质结构
Chenqing Wu1, Haoting Wu1, Cheng Zhou1
1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
CNS neuroscience & therapeutics
|November 23, 2023
概括
在帕金森病 (PD) 中,多巴胺替代疗法 (DRT) 与皮质缩有关,特别是在前额叶皮质. 仔细管理DRT剂量对于减轻这些结构性大脑变化至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 放射学 放射学是一门学科.
背景情况:
- 帕金森病 (PD) 是一种影响运动功能的神经退行性疾病.
- 多巴胺替代疗法 (DRT) 是PD症状的主要治疗方法.
- 慢性DRT对PD患者大脑结构的影响仍然是积极调查的领域.
研究的目的:
- 研究帕金森病 (PD) 患者的皮质结构重组,这些患者接受慢性多巴胺替代疗法 (DRT).
- 分析横截面和纵向数据以了解这些结构变化.
- 确定皮质变化与PD患者临床结果之间的关联.
主要方法:
- 对61名DRT治疗的PD患者,60名未经治疗的PD患者和61名正常对照 (NC) 的回顾性分析.
- 进行了结构性MRI扫描和神经心理测试.
- 使用FreeSurfer,一般线性模型和线性混合效应模型分析了皮层厚度和体积.
主要成果:
- 在DRT治疗的PD患者的前额叶皮质中观察到显著的皮质缩,包括右侧骨干,双侧上额叶皮质 (SFC) 和左侧前额叶皮质 (rACC).
- 左侧SFC体积与勒沃多巴等效剂量 (LED) 和药物持续时间负相关.
- 左侧SFC体积与数字跨度前进得分积极相关,并与增加的LED纵向相关.
结论:
- 多巴胺替代疗法 (DRT) 影响帕金森病 (PD) 患者的皮质结构.
- 研究结果强调了优化DRT剂量的重要性,以潜在地减轻大脑结构变化.
- 需要进一步的研究才能充分阐明DRT对大脑结构和功能的长期影响.
相关概念视频
01:24Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278
01:15Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K